Nuzzel
  • Discover
  • Newsletters
  • Sign In
    • Sign In via

      Sign In with Twitter
Image not available

Amanda Sebring's Newsletter Archive

Fri, Jan 22 2021

Subscribe to Amanda Sebring's Newsletter You are subscribed to Amanda Sebring's newsletter

Congratulations! you are now subscribed to
Amanda Sebring's newsletter.

Tell your friends about this newsletter 😎

Share on Twitter Share on Facebook
Share on Twitter Share on Facebook
Hello and welcome to my Nuzzel newsletter! Amanda Sebring
Image not available
Emerging Coronavirus Variants May Pose Challenges to Vaccines
The New York Times – Apoorva Mandavilli – Jan 20, 3:37 PM

The steady drumbeat of reports about new variants of the coronavirus — first in Britain, then in South Africa, Brazil and the United States — have brought a new worry: Will vaccines protect against these altered versions of the virus?

More info…
Image not available
Coronavirus Disease 2019 (COVID-19)
Centers for Disease Control and Prevention – Feb 11, 2020

CDC is responding to a pandemic of coronavirus disease 2019 (COVID-19) caused by a novel coronavirus, SARS-CoV-2, that is spreading from person to person. The federal government is working closely with state, tribal, local, and territorial health…

More info…
Image not available
U.S. Covid Vaccine Supply: How to Make Sense of Those Confusing Numbers
The New York Times – Katie Thomas – Jan 21, 9:23 AM

Demand for vaccines is skyrocketing as the United States grapples with a record death toll from Covid-19 and the threat of new, more contagious variants. After a slow start in December, many states and cities have quickly ramped up vaccine…

More info…
Image not available
Upcoming 2020-2021 Influenza Season
Centers for Disease Control and Prevention – Aug 31, 2020

Note: “ Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices — United States, 2020-2021 Influenza Season ” has been published. CDC recommends annual…

More info…
Effect of Bamlanivimab Alone vs With Etesevimab on Viral Load in Patients With Mild to Moderate COVID-19
The JAMA Network – Dec 11, 2020

Key Points Questions What is the effect of early treatment with antispike neutralizing antibodies on severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) viral load in outpatients with mild to moderate coronavirus disease 2019 (COVID-19)?

More info…
Previous Issue Next Issue
@AmandaSebring
Amanda's newsletter issues
  • Wed, Feb 24, 2021
  • Tue, Feb 23, 2021
  • Mon, Feb 22, 2021
  • Sun, Feb 21, 2021
  • Sat, Feb 20, 2021
More Featured Feeds
  • MichaelDell Michael Dell
  • JoshMalina Joshua Malina
  • Ghonim Wael Ghonim 🦅

Nuzzel is the super-easy way to see news from your friends.

Discover the best news stories shared by your friends on Facebook and Twitter without being overwhelmed or missing anything.
Get it on Google Play
  • Get it on Google Play
Nuzzel® is a registered trademark of Nuzzel, Inc.
© 2018 Nuzzel, Inc. | About | Jobs | Blog | Terms | Privacy | Advertise

Discover more stories

by subscribing to Amanda Sebring's newsletter

Thanks for subscribing!

Let your friends know

Share on Twitter Share on Facebook